Senate panel hears of conflict in drugmaker-doctor relations

06/27/2007 | Washington Post, The · NYTimes.com

Nearly two-thirds of the cost of continuing education courses in medicine is sponsored by drugmakers, according to testimony at a Senate committee hearing. A pharmaceutical industry executive said funding of continuing medical education is an important way to give physicians the latest medical and scientific research news.

View Full Article in:

Washington Post, The · NYTimes.com

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
MGR POST MARKET STUDIES - 14000001LK
Abbott
Santa Ana, CA
Regulatory Analyst
Delta Dental
Alpharetta, GA
Associate Director, Regulatory Affairs - Promotional Review
Novo Nordisk
Princeton, NJ
Eastern Zone Sales Director
Regenesis Biomedical
Multiple Locations, SL_Multiple Locations
Senior Financial Analyst - Growing Manager Care Health Org
Fallon Community Health Plan
Worcester, MA